Finally, real visibility into your investigator grants.
Investigator costs are large, complex, and notoriously difficult to track. Harder still, the data needed to do it accurately is scattered across disconnected systems (or in no systems at all). Auxilius integrates disparate data sources, giving you a unified, real-time view of your investigator grants – with insights to drive better decisions.
.avif)
Investigator spend, tracked and forecasted in real time
End-to-end investigator transparency
From the moment site budgets are negotiated through end-of-study reconciliation, Auxilius provides a single source of truth to manage investigator grants spend.
%201.svg)
Accuracy for your most variable cost category
Investigator spend is the most volatile, hardest to predict cost in any trial. Forecast it down to the patient level using your own protocols, contracted costs, and enrollment data.
Insights that compound as your programs grow
Every study you manage on Auxilius adds to your unified dataset, giving you cross-portfolio perspective and actionable insights to manage active studies and plan for future ones.
Everything you need to manage the full lifecycle of your investigator grants
Capabilities purpose-built to forecast, track, and reconcile investigator grants – all in one place.
%201.svg)
Automated integration of CTA, EDC, and payments data
Auxilius maps and integrates your site contracts, EDC data, and payments data into a single data model – no manual data entry, no wrangling ClinOps for trial updates.
Investigator grant cost tracking
Calculate life-to-date expenses directly from trial activity and contracted costs – with transaction-level detail across every site, region, and patient group in your study.
Investigator dashboard
Get a portfolio-level view of investigator spend across all your studies, with total costs, enrolled patients, and trends by site, region, and invoiceable category, all in one place.
Investigator cost forecasting
Investigator grants move with every enrolling patient, every site contract, every discontinuation; Auxilius builds the forecast from your own clinical data, patient by patient and site by site, to make an accurate investigator forecast possible.
Investigator payments reconciliation
Auxilius validates every site payment against your own clinical data, transaction by transaction – catching overbillings, duplicate charges, and unbilled costs across every site, region, and study in your portfolio.
Pro forma invoicing
Proactively generate site-level invoices from your own clinical data with standard payment rules built in, so your sites get paid accurately and on time.
Frequently Asked Questions
Investigator Spend Intelligence integrates data from your Clinical Trial Agreements (CTAs) , Electronic Data Capture (EDC) data, and protocols into a single, structured dataset, transaction by transaction across every site, visit and invoiceable procedure. That unified data foundation powers accurate investigator expense calculations, forecasting, payment reconciliation, and even pro-forma invoice preparation. It gives you visibility into site-level spend patterns and detail you'd never see in a vendor estimate.
Auxilius automatically pulls visit, procedure and site costs from your Clinical Trial Agreements (CTAs), Electronic Data Capture (EDC) systems, and CRO payment reports, and maps it all into one unified dataset using our proprietary data ontologies and taxonomies. Auxilius maintains therapeutic-area specific ontologies to ensure accuracy in the most complex clinical trials. Every addition goes through a QA/QC process before it's added, so the dataset stays accurate as your trial progresses.
As part of Auxilius’ standard implementation, the Auxilius clinical team reviews the protocol, Clinical Trial Agreements (CTAs), Electronic Data Capture (EDC) architecture file to determine the appropriate source files to capture the visits and conditional procedures. Auxilius receives enrollment and visit information from the study's EDC system, Interactive Response Technology (IRT), and/or the Clinical Trial Management System (CTMS).
Auxilius extracts site budget data directly from each site's executed Clinical Trial Agreement (CTA) using proprietary automation and data mapping capabilities. Clinical data experts review line items where clinical judgment is required. Every extraction goes through a QA/QC process before it's incorporated, ensuring the data feeding into forecasting, expense estimation, and reconciliation is accurate.
When Electronic Data Capture (EDC) data lags, Auxilius can predict which patient visits should have occurred based on protocol schedules. Auxilius calculates the potential exposure and enables users to include as a topside adjustment to the investigator cost estimates. Sponsors can add manual transactions to the Investigator model to capture any additional adjustments required, complete with an audit trail.
Auxilius maintains a normalized data ontology mapping visit, milestone, cost, and payments data to a common structure. With this data taxonomy in place, site payment reports from your CRO can be compared against investigator transactions in the Auxilius platform, identifying duplicate billing, overbilling, and underbilling, even when neither source uses the same labels or level of detail.
Yes. Auxilius' pro forma payments service generates site-level invoices directly from your investigator transaction data. Auxilius’ proprietary payments engine builds site-specific logic to ensure invoices are compliant and accurate. Auxilius exports invoices to sponsor Procure-to-day (P2P) or Enterprise Resource Planning (ERP) to enable direct payment through Sponsor’s own payments system.
Discover a new approach to clinical trial financial management
